Tebentafusp-tebn With LDT in Metastatic UM

NCT06626516 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Uveal Melanoma

Interventions

DRUG: Tebentafusp-Tebn
DRUG: GM-CSF (Sargramostim)
DRUG: BCNU

Sponsor

Thomas Jefferson University

Collaborators

[object Object]